Optimal Medical Therapy for Known Coronary Artery Disease: A Review

Raymond J Gibbons1, Todd D Miller1

  • 1Mayo Clinic, Rochester, Minnesota.

JAMA Cardiology
|July 13, 2017
PubMed

Insights

Optimal medical therapy (OMT) for coronary artery disease prevents recurrent events. However, OMT delivery is suboptimal, necessitating quality improvements in patient education and compliance interventions for better public health outcomes.

Area of Science:

  • Cardiology
  • Public Health
  • Health Services Research

Background:

  • Optimal medical therapy (OMT) is crucial for secondary prevention in patients with coronary artery disease (CAD).
  • Current American College of Cardiology Foundation/American Heart Association guidelines recommend OMT for preventing recurrent cardiovascular events.
  • OMT offers significant public health benefits by reducing mortality and morbidity in CAD patients.

Purpose of the Study:

  • To review the current state of optimal medical therapy (OMT) for patients with coronary artery disease (CAD).
  • To assess the effectiveness of OMT in preventing recurrent cardiovascular events and its public health impact.
  • To identify areas for quality improvement in the delivery of OMT.

Main Methods:

  • Review of current literature on optimal medical therapy (OMT) for coronary artery disease (CAD).
  • Analysis of evidence from randomized trials and studies utilizing pharmacy records.
  • Examination of existing quality improvement strategies and performance measures.

Main Results:

  • Evidence indicates that the delivery of OMT for CAD is not meeting ideal standards.
  • Studies highlight significant gaps in the implementation of recommended OMT protocols.
  • Current practices show suboptimal patient adherence and suboptimal use of guideline-directed medical therapies.

Conclusions:

  • Improving OMT delivery is essential for secondary prevention in CAD patients.
  • Enhanced patient education and interventions to improve compliance are recommended.
  • Implementing performance measures focused on long-term OMT is crucial for quality improvement and reducing CAD-related mortality.
Abstract

Related Concept Videos

Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
343
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
770
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
337
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
359
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
512
Angina V: Nursing Management01:20

Angina V: Nursing Management

Angina, a symptom of myocardial ischemia, requires a structured nursing management approach to ensure effective care and prevent complications like myocardial infarction. Comprehensive nursing care involves assessing, diagnosing, planning, implementing interventions, and evaluating outcomes, all tailored to the individual patient's needs.Patient AssessmentNursing assessment begins with a detailed subjective evaluation of symptoms, which typically include chest pain or pressure radiating to the...
419